NCT05608954

Brief Summary

Cerebral Palsy (CP) refers to childhood movement and posture disorders, whose severity, patterns of motor involvement and associated impairments are very varied. It is the most prevalent type of physical disability in children. Any non-progressive central nervous system (CNS) lesion that occurs in the prenatal, perinatal and postnatal period up to 2 years of life is considered CP. Thus, the present work aims to evaluate, monitor and verify the effects of physical therapy interventions on gross motor function, spasticity, balance, muscle activation, fatigue, respiratory system, functionality and social participation in children with cerebral palsy. This work will use some evaluation scales such as the Gross Motor Function Measure (GMFM-66), the Modified Ashworth Scale (MAS), the Early Clinical Assessment of Balance (ECAB), electromyography, the Fatigue Severity Scale and the Pediatric Functional Status. Scale. In addition to questionnaires, which will be applied directly to parents/caregivers, such as the Young Children's Participation and Environment Measure (YC-PEM), the PEDI (Pediatric Evaluation Disability Inventory) and the Goal Attainment Scaling (GAS).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
33

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 5, 2022

Completed
9 months until next milestone

First Posted

Study publicly available on registry

November 8, 2022

Completed
22 days until next milestone

Study Start

First participant enrolled

November 30, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

December 14, 2022

Status Verified

December 1, 2022

Enrollment Period

5 months

First QC Date

February 5, 2022

Last Update Submit

December 12, 2022

Conditions

Keywords

Cerebral PalsyPhysical Therapy ModalitiesLongitudinal StudiesDisabled Children

Outcome Measures

Primary Outcomes (2)

  • Gross Motor Function

    Measurement of Gross Motor Function

    1 year

  • Gross Motor Function Classification System

    Scale Gross Motor Function Classification System

    Levels I - V. Higher scores mean a worse outcome

Secondary Outcomes (8)

  • Electromyography

    1 year

  • Early Clinical Assessment of Balance - ECAB

    1 year

  • Modified Ashworth Scale (MAS)

    1 year

  • Fatigue Severity Scale

    1 year

  • Pediatric Functional Status Scale

    1 year

  • +3 more secondary outcomes

Study Arms (1)

Physical Therapy Modalities

Children diagnosed with cerebral palsy will be followed longitudinally in their therapies within the physiotherapeutic treatment.

Other: Bobath ConceptOther: PediasuitOther: Locomotor trainingOther: StretchingOther: PsychomotricityOther: Virtual reality

Interventions

Handling of the Bobath Concept

Physical Therapy Modalities

Pediasuit

Physical Therapy Modalities

Locomotor training

Physical Therapy Modalities

Active, passive, active-assisted stretching

Physical Therapy Modalities

Psychomotor skills

Physical Therapy Modalities

Virtual reality

Physical Therapy Modalities

Eligibility Criteria

Age0 Months - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children from 0 to 12 years old, diagnosed with cerebral palsy

You may qualify if:

  • clinical diagnosis of Cerebral Palsy
  • aged between 0-12 years
  • classified in all the levels of the GMFCS
  • those responsible agree to release the minor to participate in the study and sign the Free and Informed Consent Form (FICT)

You may not qualify if:

  • have had botulinum toxin applied 6 months before the intervention
  • recent surgery
  • other physical abnormalities, genetic or severe syndromes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Franciele Zardo

Porto Alegre, Rio Grande do Sul, Brazil

RECRUITING

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Franciele Zardo, Msc

    UFCSPA: Universidade Federal de Ciencias da Saude de Porto Alegre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fernanda Cechetti, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 5, 2022

First Posted

November 8, 2022

Study Start

November 30, 2022

Primary Completion

May 1, 2023

Study Completion

March 1, 2024

Last Updated

December 14, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations